Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China · Delayed Price · Currency is CNY 4.660
-0.140 (-2.92%)
Nov 13, 2026, 3:04 PM CST
SHE:300158 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 349.5 | 511.9 | 584.59 | 800.88 | 720.27 | 1,222 |
Short-Term Investments | - | - | 5.01 | - | - | - |
Trading Asset Securities | 410.01 | 489.97 | 989.62 | 1,448 | 2,019 | 4,470 |
Cash & Short-Term Investments | 759.51 | 1,002 | 1,579 | 2,249 | 2,740 | 5,692 |
Cash Growth | -1.96% | -36.56% | -29.78% | -17.91% | -51.87% | 508.77% |
Accounts Receivable | 608.28 | 890 | 718.07 | 856.04 | 809.3 | 945.55 |
Other Receivables | 79.67 | 54.9 | 57.75 | 44.71 | 57.44 | 502.55 |
Receivables | 687.95 | 944.9 | 775.81 | 900.75 | 866.74 | 1,448 |
Inventory | 637.63 | 649.91 | 775.98 | 1,195 | 1,074 | 937.14 |
Prepaid Expenses | - | 0.19 | 6.11 | 4.18 | 0.91 | 2.52 |
Other Current Assets | 85.39 | 71.32 | 78.49 | 111.08 | 201.62 | 344.11 |
Total Current Assets | 2,170 | 2,668 | 3,216 | 4,460 | 4,883 | 8,424 |
Property, Plant & Equipment | 1,113 | 1,107 | 1,046 | 994.9 | 1,010 | 1,047 |
Long-Term Investments | 109.1 | 78.73 | 38.65 | 57.02 | 58.34 | 58.3 |
Goodwill | 15.5 | 15.5 | 15.5 | 40.24 | 40.24 | 40.24 |
Other Intangible Assets | 336.13 | 331.46 | 288.85 | 260.07 | 258.39 | 250.37 |
Long-Term Accounts Receivable | - | - | - | - | 0.12 | 1.11 |
Long-Term Deferred Tax Assets | 25.5 | 28.13 | 24.97 | 21.01 | 18.87 | 23.83 |
Long-Term Deferred Charges | 148.35 | 135.97 | 101.37 | 200.37 | 201.06 | 195.49 |
Other Long-Term Assets | 269.51 | 257.58 | 251.29 | 146.6 | 80.41 | 53.21 |
Total Assets | 4,187 | 4,622 | 4,983 | 6,180 | 6,551 | 10,093 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 286.29 | 345.29 | 328.01 | 418 | 504.48 | 584.92 |
Accrued Expenses | 27.47 | 264.42 | 229 | 251.35 | 289.2 | 410.52 |
Short-Term Debt | 233.8 | 176.96 | 38.11 | 0.1 | 20.48 | 210.77 |
Current Portion of Leases | 2.12 | 1.53 | 2.01 | 1.22 | 0.31 | 0.73 |
Current Income Taxes Payable | 14.11 | 2.73 | 0.54 | - | 9.33 | 422.7 |
Current Unearned Revenue | 54.74 | 53.93 | 51.42 | 68.42 | 147.59 | 86.59 |
Other Current Liabilities | 342.72 | 425.15 | 605.94 | 177.98 | 237.93 | 83.86 |
Total Current Liabilities | 961.25 | 1,270 | 1,255 | 917.07 | 1,209 | 1,800 |
Long-Term Debt | 45.83 | - | 0.18 | 0.18 | - | 100.14 |
Long-Term Leases | 4.55 | 6.15 | 1.09 | 1.53 | 1.08 | 1.08 |
Long-Term Unearned Revenue | 38.17 | 35.29 | 37.65 | 42.77 | 42.49 | 56.38 |
Long-Term Deferred Tax Liabilities | 0.17 | 1.12 | 0.98 | 0.3 | - | - |
Other Long-Term Liabilities | - | - | 27.54 | 74.54 | 74.72 | 81.3 |
Total Liabilities | 1,050 | 1,313 | 1,322 | 1,036 | 1,328 | 2,039 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 992.3 | 992.3 | 1,005 | 1,027 | 1,027 | 1,027 |
Additional Paid-In Capital | 3,644 | 3,643 | 3,682 | 3,762 | 3,762 | 3,762 |
Retained Earnings | -1,380 | -1,208 | -906.81 | 421.76 | 465.74 | 3,291 |
Treasury Stock | - | - | -2.84 | - | - | - |
Comprehensive Income & Other | -78.43 | -78.68 | -79.78 | -32.71 | -1.39 | -1.47 |
Total Common Equity | 3,177 | 3,349 | 3,698 | 5,179 | 5,254 | 8,080 |
Minority Interest | -39.99 | -39.4 | -37.37 | -34.75 | -30.86 | -25.15 |
Shareholders' Equity | 3,137 | 3,310 | 3,660 | 5,144 | 5,223 | 8,054 |
Total Liabilities & Equity | 4,187 | 4,622 | 4,983 | 6,180 | 6,551 | 10,093 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 286.3 | 184.63 | 41.39 | 3.03 | 21.87 | 312.72 |
Net Cash (Debt) | 473.21 | 817.23 | 1,538 | 2,246 | 2,718 | 5,379 |
Net Cash Growth | -36.84% | -46.86% | -31.52% | -17.36% | -49.48% | 1003.25% |
Net Cash Per Share | 0.48 | 0.81 | 1.50 | 2.19 | 2.64 | 5.24 |
Filing Date Shares Outstanding | 992.3 | 992.3 | 1,024 | 1,027 | 1,027 | 1,027 |
Total Common Shares Outstanding | 992.3 | 992.3 | 1,024 | 1,027 | 1,027 | 1,027 |
Working Capital | 1,209 | 1,398 | 1,961 | 3,543 | 3,674 | 6,623 |
Book Value Per Share | 3.20 | 3.37 | 3.61 | 5.04 | 5.11 | 7.86 |
Tangible Book Value | 2,826 | 3,002 | 3,393 | 4,879 | 4,956 | 7,789 |
Tangible Book Value Per Share | 2.85 | 3.03 | 3.31 | 4.75 | 4.82 | 7.58 |
Buildings | - | 1,239 | 1,168 | 1,144 | 1,094 | 1,033 |
Machinery | - | 925.07 | 862.65 | 832.12 | 824.63 | 783.61 |
Construction In Progress | - | 125.25 | 119.4 | 44.98 | 24.21 | 19.89 |